🇺🇸 GILD — Gilead Sciences, Inc.

Healthcare Compra
← Volver

Precio actual

151,00 USD

Máx. histórico

157,29

205 días

Split 2:1 del 28/01/2013

Caída desde máximo

-4,00%

Rango 52 semanas

108,46 – 157,29

Variación hoy

-0,15%

Cierre anterior

151,22

Rango de hoy

149,23 – 151,19

Volumen hoy

6.181.783

Información
Nombre completo
Gilead Sciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
17.000
PER
Dividend yield
2,17% (puede no estar actualizado)
Precio objetivo analistas
157,41 USD (puede no estar actualizado)
Primera cotización
22/01/1992
Precio actualizado
hace 3 días
Sobre la empresa

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspension for intravenous infusion, is a CAR T-cell therapy for the treatment of adult patients. Further, it provides AmBisome, for the treatment of serious invasive fungal infections; and Veklury for the treatment of COVID-19. Additionally, the company engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company has collaboration agreements with Shenzhen Pregene Biopharma Co., Ltd.; Abingworth; Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company has a collaboration with Terray Therapeutics, Inc. to discover and develop small molecule therapies; and LEO Pharma to develop, manufacture, and commercialize the small molecule oral STAT6 program. The company was incorporated in 1987 and is headquartered in Foster City, California.

Dividendos repartidos Total últimos 12 meses: 3,2200 USD · Yield: 2,13%
Fecha de pago Importe por participación
14/09/2022 0,7300 USD
14/06/2022 0,7300 USD
14/03/2022 0,7300 USD
14/12/2021 0,7100 USD
14/09/2021 0,7100 USD
14/06/2021 0,7100 USD
12/03/2021 0,7100 USD
14/12/2020 0,6800 USD
14/09/2020 0,6800 USD
11/06/2020 0,6800 USD
12/03/2020 0,6800 USD
12/12/2019 0,6300 USD
12/09/2019 0,6300 USD
13/06/2019 0,6300 USD
14/03/2019 0,6300 USD
Splits Registrados en el histórico de precios
Fecha Ratio
28/01/2013 2:1
25/06/2007 2:1
07/09/2004 2:1
08/03/2002 2:1
22/02/2001 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
14/02/2012 27,14 27,45 27,08 27,28 -0,62% 1,36% 14.643.000
13/02/2012 26,89 27,49 26,86 27,45 +2,14% 2,32% 14.034.800
10/02/2012 26,80 26,98 26,71 26,88 +0,04% 1,01% 14.493.000
09/02/2012 27,20 27,20 26,77 26,87 -1,00% 1,56% 15.745.800
08/02/2012 27,28 27,45 26,92 27,14 -1,47% 1,96% 23.592.000
07/02/2012 27,60 27,94 27,33 27,54 -1,70% 2,21% 27.495.600
06/02/2012 27,15 28,25 27,12 28,02 +2,43% 4,16% 37.824.600
03/02/2012 26,71 27,45 26,50 27,35 +10,93% 3,56% 75.343.200
02/02/2012 24,56 24,82 24,19 24,66 +0,33% 2,57% 17.363.600
01/02/2012 24,53 24,70 24,44 24,58 +0,59% 1,08% 19.617.600
31/01/2012 24,23 24,44 24,19 24,43 +0,43% 1,05% 13.315.800
30/01/2012 24,24 24,45 24,00 24,33 -0,14% 1,84% 14.153.400
27/01/2012 24,29 24,50 24,17 24,36 +0,27% 1,36% 16.363.800
26/01/2012 24,29 24,39 23,93 24,30 +0,62% 1,91% 18.193.200
25/01/2012 23,72 24,24 23,72 24,15 +1,30% 2,21% 15.804.800
24/01/2012 23,66 23,93 23,54 23,84 +0,63% 1,67% 15.147.400
23/01/2012 23,57 23,72 23,51 23,69 -0,15% 0,89% 15.997.800
20/01/2012 23,57 23,73 23,42 23,72 +0,49% 1,34% 14.076.000
19/01/2012 23,64 23,74 23,40 23,61 -0,63% 1,46% 24.058.000
18/01/2012 23,16 23,78 23,05 23,76 +2,70% 3,13% 26.292.400
17/01/2012 22,50 23,25 22,44 23,13 +3,05% 3,62% 24.215.200
13/01/2012 22,29 22,50 22,00 22,45 -0,02% 2,22% 18.483.000
12/01/2012 22,19 22,49 21,99 22,45 +1,13% 2,25% 15.342.400
11/01/2012 22,03 22,30 21,89 22,20 +0,34% 1,86% 15.471.000
10/01/2012 21,55 22,52 21,47 22,13 +3,56% 4,87% 30.110.000
09/01/2012 21,25 21,50 21,18 21,37 -0,12% 1,51% 16.801.200
06/01/2012 21,19 21,55 21,10 21,39 +0,61% 2,12% 15.542.000
05/01/2012 21,02 21,49 21,00 21,26 +1,19% 2,31% 18.431.800
04/01/2012 20,98 21,03 20,85 21,01 +0,38% 0,86% 16.236.000
03/01/2012 20,73 21,00 20,68 20,93 +2,27% 1,54% 19.564.000